Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Account Payables (2017 - 2021)

Cogent Biosciences has reported Change in Account Payables over the past 5 years, most recently at -$866000.0 for Q4 2021.

  • Quarterly results put Change in Account Payables at -$866000.0 for Q4 2021, down 1031.18% from a year ago — trailing twelve months through Dec 2021 was $2.8 million (up 212.24% YoY), and the annual figure for FY2025 was -$2.5 million, down 284.76%.
  • Change in Account Payables for Q4 2021 was -$866000.0 at Cogent Biosciences, down from $2.4 million in the prior quarter.
  • Over the last five years, Change in Account Payables for COGT hit a ceiling of $2.4 million in Q3 2021 and a floor of -$2.6 million in Q1 2020.
  • Median Change in Account Payables over the past 5 years was $5500.0 (2020), compared with a mean of $115000.0.
  • Peak annual rise in Change in Account Payables hit 41825.0% in 2021, while the deepest fall reached 1031.18% in 2021.
  • Cogent Biosciences' Change in Account Payables stood at -$774000.0 in 2017, then surged by 192.51% to $716000.0 in 2018, then soared by 121.93% to $1.6 million in 2019, then crashed by 94.15% to $93000.0 in 2020, then crashed by 1031.18% to -$866000.0 in 2021.
  • The last three reported values for Change in Account Payables were -$866000.0 (Q4 2021), $2.4 million (Q3 2021), and $1.7 million (Q2 2021) per Business Quant data.